UK biotech financing 2024
The UK biotech sector achieved significant growth in 2024, raising £3.5 billion in investment—a staggering 94% increase compared to the previous year. This represents the highest annual figure since the £4.5 billion raised in 2021 and is a testament to the sector’s resilience, innovation, and global appeal, even in the face of challenging economic conditions.
The new figures are revealed in the BioIndustry Association’s (BIA) annual UK biotech financing report. Despite the welcome increase, investment was concentrated in a small number of companies that raised big rounds, primarily from US investors, who are increasingly attracted to the UK sector.
Looking to 2025, we expect a slight pick-up in IPOs but much rests on how the markets react to the new US President. This will also feed into the private markets. Despite the challenges faced in 2024, the strong VC deals of the year set the stage for continued investment and growth in the biotech industry, ensuring that the sector remains poised for recovery and long-term success.
